CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment-Reference-Cited by-同舟云学术

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

Published:2005-01-04 Issue:1 Volume:97 Page:30-39
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Jin Y.,Desta Z.,Stearns V.,Ward B.,Ho H.,Lee K.-H.,Skaar T.,Storniolo A. M.,Li L.,Araba A.,Blanchard R.,Nguyen A.,Ullmer L.,Hayden J.,Lemler S.,Weinshilboum R. M.,Rae J. M.,Hayes D. F.,Flockhart D. A.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/97/1/30/9644345/dji005.pdf

Reference33 articles.

1. Tamoxifen in the Treatment of Breast Cancer

2. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

3. Hot flushes

4. Venlafaxine oxidation in vitro is catalysed by CYP2D6

5. A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd

Cited by 799 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7;Cell Calcium;2024-11

2. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

3. Hallmarks of cancer resistance;iScience;2024-06

4. Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and Opportunities;Current Drug Metabolism;2024-05

5. Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case–control study;European Archives of Psychiatry and Clinical Neuroscience;2024-03-30